103 related articles for article (PubMed ID: 25421668)
21. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
[TBL] [Abstract][Full Text] [Related]
22. Peroxiredoxin IV protects cells from radiation-induced apoptosis in head-and-neck squamous cell carcinoma.
Park JJ; Chang HW; Jeong EJ; Roh JL; Choi SH; Jeon SY; Ko GH; Kim SY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1196-202. PubMed ID: 19251091
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic and genetic alterations-based molecular classification of head and neck cancer.
Feng Z; Xu Q; Chen W
Expert Rev Mol Diagn; 2012 Apr; 12(3):279-90. PubMed ID: 22468818
[TBL] [Abstract][Full Text] [Related]
24. Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers.
Azad AK; Bairati I; Samson E; Cheng D; Cheng L; Mirshams M; Savas S; Waldron J; Wang C; Goldstein D; Xu W; Meyer F; Liu G
Cancer; 2012 Mar; 118(6):1554-65. PubMed ID: 22009713
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D
Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887
[TBL] [Abstract][Full Text] [Related]
26. Low-dose radiation-induced responses: focusing on epigenetic regulation.
Ma S; Liu X; Jiao B; Yang Y; Liu X
Int J Radiat Biol; 2010 Jul; 86(7):517-28. PubMed ID: 20545569
[TBL] [Abstract][Full Text] [Related]
27. DNA Methylation in Radiation-Induced Carcinogenesis: Experimental Evidence and Clinical Perspectives.
Miousse IR; Ewing LE; Kutanzi KR; Griffin RJ; Koturbash I
Crit Rev Oncog; 2018; 23(1-2):1-11. PubMed ID: 29953365
[TBL] [Abstract][Full Text] [Related]
28. Regulation of epigenetic modifications in the head and neck tumour microenvironment.
Liu H; Wang D; Yang Z; Li S; Wu H; Xiang J; Kan S; Hao M; Liu W
Front Immunol; 2022; 13():1050982. PubMed ID: 36405713
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inactivation of RASSF1A in head and neck cancer.
Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151
[TBL] [Abstract][Full Text] [Related]
30. Translational genomics and head and neck cancer: toward precision medicine.
Razzouk S
Clin Genet; 2014 Nov; 86(5):412-21. PubMed ID: 25143247
[TBL] [Abstract][Full Text] [Related]
31. Current evidence for a role of epigenetic mechanisms in response to ionizing radiation in an ecotoxicological context.
Horemans N; Spurgeon DJ; Lecomte-Pradines C; Saenen E; Bradshaw C; Oughton D; Rasnaca I; Kamstra JH; Adam-Guillermin C
Environ Pollut; 2019 Aug; 251():469-483. PubMed ID: 31103007
[TBL] [Abstract][Full Text] [Related]
32. Radiosensitization of head/neck squamous cell carcinoma by adenovirus-mediated expression of the Nbs1 protein.
Rhee JG; Li D; Suntharalingam M; Guo C; O'Malley BW; Carney JP
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):273-8. PubMed ID: 17189075
[TBL] [Abstract][Full Text] [Related]
33. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
34. Antisense inhibition of ATM gene enhances the radiosensitivity of head and neck squamous cell carcinoma in mice.
Zou J; Qiao X; Ye H; Yang Y; Zheng X; Zhao H; Liu S
J Exp Clin Cancer Res; 2008 Oct; 27(1):56. PubMed ID: 18950535
[TBL] [Abstract][Full Text] [Related]
35. A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck.
Hanna E; Shrieve DC; Ratanatharathorn V; Xia X; Breau R; Suen J; Li S
Cancer Res; 2001 Mar; 61(6):2376-80. PubMed ID: 11289099
[TBL] [Abstract][Full Text] [Related]
36. Role of neurofilament light polypeptide in head and neck cancer chemoresistance.
Chen B; Chen J; House MG; Cullen KJ; Nephew KP; Guo Z
Mol Cancer Res; 2012 Mar; 10(3):305-15. PubMed ID: 22246235
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic regulation of TGF-β pathway and its role in radiation response.
Ding Y; Zhou G; Hu W
Int J Radiat Biol; 2024; 100(6):834-848. PubMed ID: 38506660
[TBL] [Abstract][Full Text] [Related]
38. Evolving paradigms for the biological response to low dose ionizing radiation; the role of epigenetics.
Schofield PN; Kondratowicz M
Int J Radiat Biol; 2018 Aug; 94(8):769-781. PubMed ID: 29157078
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity to radiation-induced chromosome damage may be a marker of genetic predisposition in young head and neck cancer patients.
Papworth R; Slevin N; Roberts SA; Scott D
Br J Cancer; 2001 Mar; 84(6):776-82. PubMed ID: 11259091
[TBL] [Abstract][Full Text] [Related]
40. Modern molecular biomarkers of head and neck cancer. Part I. Epigenetic diagnostics and prognostics: Systematic review.
Juodzbalys G; Kasradze D; Cicciù M; Sudeikis A; Banys L; Galindo-Moreno P; Guobis Z
Cancer Biomark; 2016; 17(4):487-502. PubMed ID: 27802200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
